A lack of commercial incentives to get the drug approved for treatment-resistant depression means people cannot afford it
Follow our Australia news live blog for latest updatesGet our morning and afternoon news emails, free app or daily news podcast
After being abused as a child, David spent decades searching for a treatment for his depression and anxiety. Like many people with treatment-resistant depression, he was cycled by psychiatrists through a variety of drugs and therapies, but David – who asked for only his first name to be used – said he remained “debilitated”.
Then in October 2021, at age 64, he began a fortnightly ketamine treatment – and it proved to be a “lifesaver”.
About Author
More Stories
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’
Microsoft unveils chip it says could bring quantum computing within years
If the best defence against AI is more AI, this could be tech’s Oppenheimer moment